Personnalisez votre veille

Inscrivez-vous gratuitement.

Espace publicitaire · 728×90

Survive the Quarantine Zone and More With Devolver Digital Games on GeForce NOW

Home | NVIDIA Newsroom • Publié le 15 janvier 2026

NVIDIA kicked off the year at CES, where the crowd buzzed about the latest gaming announcements — including the native GeForce NOW app for Linux and Amazon Fire TV sticks, community-requested flight-control support and a stacked AAA lineup for the year. Check out what the creators of the YouTube channels Cloud Gaming Battle and Anytime Read Article

Espace publicitaire · 300×250

‘Largest Infrastructure Buildout In Human History’: Jensen Huang on AI’s ‘Five-Layer Cake’ at Davos

AI is becoming the foundation of the “largest infrastructure buildout in human history,” spanning energy and computing infrastructure, AI models and applications, NVIDIA founder and CEO Jensen Huang said during a World Economic Forum…

style youtuber•1 janvier 1970

🇬🇧 → 🇫🇷

CEOs of NVIDIA and Lilly Share ‘Blueprint for What Is Possible’ in AI and Drug Discovery

NVIDIA and Lilly are putting together “a blueprint for what is possible in the future of drug discovery,” NVIDIA founder and CEO Jensen Huang told attendees at a fireside chat Monday with Dave Ricks, chair and CEO of Lilly. The…

style youtuber•1 janvier 1970

🇬🇧 → 🇫🇷

Siemens and NVIDIA Expand Partnership to Build the Industrial AI Operating System

Siemens and NVIDIA today announced a significant expansion of their strategic partnership to bring artificial intelligence into the real world.

style youtuber•1 janvier 1970

🇬🇧 → 🇫🇷

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

NVIDIA today announced a major expansion of NVIDIA BioNeMo™, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery.

style youtuber•1 janvier 1970

🇬🇧 → 🇫🇷

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry.

style youtuber•1 janvier 1970

🇬🇧 → 🇫🇷

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

NVIDIA today announced a major expansion of NVIDIA BioNeMo™, an open development platform that enables lab-in-the-loop workflows to develop breakthroughs in AI-driven biology and drug discovery.

style youtuber•1 janvier 1970

🇬🇧 → 🇫🇷

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

NVIDIA and Eli Lilly and Company today announced a first-of-its-kind AI co-innovation lab focused on applying AI to tackle some of the most enduring challenges in the pharmaceutical industry.

style youtuber•1 janvier 1970

🇬🇧 → 🇫🇷

AI’s Next Revolution: Multiply Labs Is Scaling Robotics-Driven Cell Therapy Biomanufacturing Labs

Startup works with leading cell therapy companies to bring robotics manufacturing into the clean room, reducing costs by more than 70% while accelerating output compared with legacy systems.

style youtuber•1 janvier 1970

Personnalisez votre veille

Articles similaires

‘Largest Infrastructure Buildout In Human History’: Jensen Huang on AI’s ‘Five-Layer Cake’ at Davos

CEOs of NVIDIA and Lilly Share ‘Blueprint for What Is Possible’ in AI and Drug Discovery

Siemens and NVIDIA Expand Partnership to Build the Industrial AI Operating System

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

AI’s Next Revolution: Multiply Labs Is Scaling Robotics-Driven Cell Therapy Biomanufacturing Labs